| Upcoming events on JOHNSON & JOHNSON |
|
| 03/02/21 | 09:10am | | Raymond James Institutional Investors Conference |
| 03/03/21 | 10:20am | | Cowen & Co. Health Care Conference |
| 04/20/21 | | Q1 2021 Earnings Release |
| 04/20/21 | 08:30am | | Q1 2021 Earnings Call |
|
| Past events on JOHNSON & JOHNSON |
|
| 02/25/21 | 10:45am | | Citigroup Healthcare Services, Medtech, Tools, & HCIT Virtual Conference |
| 02/22/21 | | Ex-dividend day for |
| 02/11/21 | | American Society of Clinical Oncology Genitourinary Cancers Symposium |
| 01/29/21 | 09:00am | | ENSEMBLE Phase 3 Trial Results Call |
|
| Upcoming sector events for JOHNSON & JOHNSON |
|
|
| |
|
| Past sector events for JOHNSON & JOHNSON |
|
|
|
|
|
| Annual results | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 (e) |
Sales
M $ |
Released
Forecast
Spread | 71 890
72 042
-0,21% | 76 450
76 321
0,17% | 81 581
81 416
0,20% | 82 059
82 193
-0,16% | 82 584
81 721
1,1% |
91 931
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread | 24 919
24 697
0,90% | 24 764
25 922
-4,5% | 28 104
29 996
-6,3% | 27 979
28 680
-2,4% | 27 145
27 951
-2,9% |
33 063
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | 21 165
21 491
-1,5% | 19 122
20 814
-8,1% | 21 175
23 631
-10% | 25 593
25 615
-0,09% | 24 574
24 992
-1,7% |
30 008
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | 19 803
20 511
-3,5% | 17 673
20 450
-14% | 17 999
21 447
-16% | 17 328
19 476
-11% | 16 497
19 030
-13% |
24 126
|
Net income
M $ |
Released
Forecast
Spread | 16 540
16 508
0,19% | 1 300
15 804
-92% | 15 297
17 666
-13% | 15 119
16 943
-11% | 14 714
15 924
-7,6% |
22 357
|
EPS
$ |
Released
Forecast
Spread | 5,93
5,86
1,3% | 0,47
5,78
-92% | 5,61
6,44
-13% | 5,63
6,47
-13% | 5,51
6,10
-9,7% |
8,25
| | Announcement Date | 01/24/2017 | 01/23/2018 | 01/22/2019 | 01/22/2020 | 01/26/2021 | |
|
|
|
| Quarterly results | 2018 Q3 | 2018 Q4 | 2019 Q1 | 2019 Q2 | 2019 Q3 | 2019 Q4 | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 | 2021 Q1 (e) | 2021 Q2 (e) | 2021 Q3 (e) | 2021 Q4 (e) | 2022 Q1 (e) |
Sales
M $ |
Released
Forecast
Spread | 20 348
20 054
1,5% | 20 394
20 267
0,63% | 20 021
19 549
2,4% | 20 562
20 388
0,85% | 20 729
20 141
2,9% | 20 747
20 825
-0,38% | 20 691
19 476
6,2% | 18 336
17 730
3,4% | 21 082
20 160
4,6% | 22 475
21 621
4,0% |
21 994
|
22 198
|
23 376
|
24 175
|
22 926
|
Operating income
(EBITDA)
M $ |
Released
Forecast
Spread | 7 439
7 144
4,1% | 5 953
6 659
-11% | 7 090
6 920
2,5% | 7 115
6 965
2,1% | 7 616
7 021
8,5% | 6 158
6 316
-2,5% | 7 622
6 870
11% | 6 910
5 182
33% | 7 657
6 832
12% | 6 112
6 406
-4,6% |
8 104
|
8 037
|
8 592
|
8 059
|
|
Operating profit
(EBIT)
M $ |
Released
Forecast
Spread | 5 708
5 383
6,0% | 4 218
5 065
-17% | 6 482
6 452
0,47% | 6 528
6 357
2,7% | 7 047
6 427
9,6% | 5 536
5 589
-0,95% | 6 964
6 209
12% | 5 184
4 750
9,1% | 7 020
6 236
13% | 5 406
5 680
-4,8% |
7 282
|
7 204
|
7 914
|
7 568
|
7 921
|
Pre-Tax Profit
(EBT)
M $ |
Released
Forecast
Spread | 4 423
|
|
| 7 041
6 639
6,1% | 5 647
|
|
|
|
|
|
|
|
|
|
|
Net income
M $ |
Released
Forecast
Spread | 3 934
| 3 042
5 337
-43% | 3 749
4 258
-12% | 5 607
5 469
2,5% | 4 833
4 139
17% | 4 010
3 825
4,8% | 5 796
3 292
76% | 3 626
2 661
36% | 3 554
4 236
-16% | 1 738
|
5 951
|
5 347
|
6 346
|
6 795
|
|
EPS
$ |
Released
Forecast
Spread | 1,44
1,81
-20% | 1,12
1,91
-41% | 1,39
1,50
-7,3% | 2,08
2,04
2,1% | 1,81
1,58
15% | 1,50
1,47
2,4% | 2,17
1,43
52% | 1,36
1,18
15% | 1,33
1,65
-19% | 0,65
1,43
-55% |
2,10
|
1,96
|
2,31
|
2,20
|
| | Announcement Date | 10/16/2018 | 01/22/2019 | 04/16/2019 | 07/16/2019 | 10/15/2019 | 01/22/2020 | 04/14/2020 | 07/16/2020 | 10/13/2020 | 01/26/2021 | | | | | |
|
Financial data source
© 2021 S&P Global Market Intelligence
|
|
© 2021 Factset
|
|
|
|
Most Wall Street workers to get lower 2020 bonuses: study |
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
Previous period
